NovoCure Ltd — Director's Dealing 2021

Mar 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2021-02-27

Reporting Person: Cordova Ashley (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-27	Ordinary Shares	M	1465	$149.10	Acquired	27677	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-27	Restricted Stock Units	$0.0	M	1465	Disposed		Ordinary Shares (1465.0)	Direct

Footnotes

F1: Fully vested as of the date hereof.